U.S. markets open in 3 hours 16 minutes

  • S&P Futures

    4,030.25
    -5.50 (-0.14%)
     

  • Dow Futures

    32,740.00
    -34.00 (-0.10%)
     

  • Nasdaq Futures

    12,836.00
    -31.25 (-0.24%)
     

  • Russell 2000 Futures

    1,792.20
    -1.10 (-0.06%)
     

  • Crude Oil

    68.98
    -0.69 (-0.99%)
     

  • Gold

    1,947.70
    +6.60 (+0.34%)
     

  • Silver

    22.59
    +0.17 (+0.74%)
     

  • EUR/USD

    1.0791
    +0.0019 (+0.17%)
     

  • 10-Yr Bond

    3.6060
    0.0000 (0.00%)
     

  • Vix

    21.73
    -2.42 (-10.02%)
     

  • GBP/USD

    1.2290
    +0.0071 (+0.58%)
     

  • USD/JPY

    132.6430
    +0.1830 (+0.14%)
     

  • Bitcoin USD

    28,159.00
    +117.80 (+0.42%)
     

  • CMC Crypto 200

    613.82
    +8.77 (+1.45%)
     

  • FTSE 100

    7,519.94
    -16.28 (-0.22%)
     

  • Nikkei 225

    27,466.61
    +520.94 (+1.93%)
     

Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program

Nkarta, Inc.
·1 min read
Nkarta, Inc.
Nkarta, Inc.

Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET

SOUTH SAN FRANCISCO, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced that it will host a conference call on Monday, December 5, 2022 at 8:00 a.m. ET to review updated clinical data from the ongoing clinical trial of NKX019, its CD19-directed CAR NK cell therapy candidate.

Conference Call and Webcast
To access the conference call, please register through this link:
https://nkarta-nkx019-clinical-update-conference-call.open-exchange.net/registration

Accompanying slides will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on the website for approximately four weeks.

About NKX019
NKX019, a wholly owned program of Nkarta, is an investigational healthy donor-derived CAR NK cell therapy targeting CD19. NKX019 is being investigated in an ongoing Phase 1 single-arm, open label, multi-center, international clinical trial that is designed to assess the safety and anti-tumor activity of NKX019 as a multi-dose, multi-cycle monotherapy and combination therapy in patients with relapsed/refractory B cell malignancies.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off-the-shelf natural killer (NK) cell therapies for cancer patients. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies and CRISPR-based genome engineering capabilities, Nkarta is building a pipeline of future cell therapies engineered for deep anti-tumor activity and intended for broad access in the outpatient treatment setting. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com


Recommended Stories

  • 'Invite me to your funeral': Jim Cramer makes a bold call on the Nasdaq — and even billionaire Elon Musk had to respond. Here are 3 ways to bet on that conviction

    Mad Money or a mad call?

  • An economist who correctly predicted the Great Financial Crisis says the world’s central banks have chosen ‘class war over financial stability’

    The Fed and other central banks want to bring down inflation at all costs. Is it worth it?

  • Elon Musk says what he thinks the Fed should do with interest rates

    Elon Musk on late Monday offered his opinion on what the Federal Reserve should do with its benchmark interest rate. The Fed's FOMC is meeting for two days this week.

  • JPMorgan Says Buy These 2 High-Yield Dividend Stocks — Including One With a 9% Yield

    Bank runs and extreme market volatility – are the shades of 1929 upon us? Probably not, the current situation, while dangerous, is unlikely to trigger an economy-wide depression. The real test, at least according to David Kelly, JPMorgan’s chief global strategist for asset management, will come on Wednesday, at the Federal Reserve’s next interest rate policy meeting. The central bank will have to determine which risk is more urgent, persistent high inflation or a bank crisis, and adjust its rece

  • Credit Suisse Collapse Burns Saudi Investors

    Saudi Crown Prince Mohammed bin Salman last year directed government-backed Saudi National Bank to make a $1.5 billion investment in Credit Suisse that his financial advisers harbored doubts about.

  • Warren Buffett’s Likely Successor Buys $24.6 Million in Berkshire Stock

    Abel, who heads the non-insurance operations of Berkshire (ticker: BRK.A, BRK.B), purchased 55 class A shares at a price of $447,259 on Friday, lifting his stake in the A shares to 228 shares. Berkshire shares rose 1% Tuesday to $460,515, and the B shares gained 0.9% to $303.85. The purchases were made on behalf of the Gregory Abel Revocable Trust on behalf of his wife, children, and other family members.

  • Delta Move Is Bad News For Southwest, United Airlines Passengers

    Airfare prices move up and down based on two major things -- passenger demand and the cost of actually flying the plane. Domestic air travel traffic for 2022 rose 10.9% compared to the prior year. The nation's air traffic in 2022 was at 79.6% of the full-year 2019 level.

  • EV-Maker Nio Surges; ‘Very Confident’ of Hitting Sales Goal

    (Bloomberg) -- Nio Inc. is “very confident” of meeting its target of doubling sales to 250,000 electric vehicles this year, Chief Financial Officer Steven Feng said, prompting the Chinese automaker’s shares to surge in Hong Kong. Most Read from BloombergBomb Threat Called In to New York Court Where Trump Hearing HeldBiden Stunts Growth in China for Chipmakers Getting US FundsSVB’s Loans to Insiders Tripled to $219 Million Before It FailedUS Studies Ways to Insure All Bank Deposits If Crisis Grow

  • UBS set for talks with Michael Klein to terminate Credit Suisse investment bank deal - FT

    UBS on Sunday agreed to buy rival Swiss bank Credit Suisse for 3 billion Swiss francs ($3.23 billion) in stock and agreed to assume up to 5 billion francs ($5.4 billion) in losses, in a shotgun merger engineered by Swiss authorities to avoid more market-shaking turmoil in global banking. Klein, a veteran dealmaker, was merging his eponymous advisory boutique into Credit Suisse's investment banking operations to create CS First Boston as a standalone business which he would have led from New York. UBS has now assigned a legal team to examine how to void the contract Credit Suisse signed with Klein in the cheapest way possible, according to the FT report, which cited people with direct knowledge of the matter.

  • ARK Invest Sells $13.5M Coinbase Shares After Steady Buying Streak

    Before this sale, ARK Invest owned 9.9 million shares of the crypto exchange worth $575 million.

  • The Blunt Layoff Message Amazon CEO Andy Jassy Wrote to Workers

    When Amazon announced it was eliminating 9,000 jobs March 20, CEO Andy Jassy wrote a message that was posted to an Amazon blog. The new layoffs were to affect Amazon Web Services (AWS), People Experience and Technology Solutions (PXT Solutions), advertising and the video live streaming service Twitch.

  • First Republic Shares Inch Higher as Eyes Turn to Rescue Talks

    (Bloomberg) -- First Republic Bank shares rose in early trading as all eyes remained on how talks aimed at shoring up the midsize lender were progressing amid a crisis of confidence.Most Read from BloombergBomb Threat Called In to New York Court Where Trump Hearing HeldBiden Stunts Growth in China for Chipmakers Getting US FundsSVB’s Loans to Insiders Tripled to $219 Million Before It FailedUS Studies Ways to Insure All Bank Deposits If Crisis GrowsSwiss Are On the Hook for $13,500 Each on Credi

  • JPMorgan is the unlucky owner of the fake nickel uncovered by the London Metal Exchange—really just bags of rocks

    It's the second scandal involving fake nickel in as many months.

  • UBS Offers to Buy Back Bonds Sold Before Credit Suisse Deal

    (Bloomberg) -- UBS Group AG is offering to buy back 2.75 billion euros ($3 billion) worth of bonds it issued to investors just days before rescuing Credit Suisse Group AG. Most Read from BloombergBomb Threat Called In to New York Court Where Trump Hearing HeldBiden Stunts Growth in China for Chipmakers Getting US FundsSVB’s Loans to Insiders Tripled to $219 Million Before It FailedUS Studies Ways to Insure All Bank Deposits If Crisis GrowsSwiss Are On the Hook for $13,500 Each on Credit Suisse B

  • Tencent's annual revenue drops for first time as China crackdown bites

    (Reuters) -Tencent Holdings reported a drop in annual revenue for the first time ever, as China's economic slowdown due to the pandemic and a long-running regulatory crackdown took a toll. Tencent's profit attributable to equity holders fell 16% to 188.24 billion yuan for the year, versus a consensus estimate of 114.19 billion yuan. The results come amid an uncertain business outlook in the world's largest gaming market after two years of crackdown, but sector participants are cautiously optimistic about a recovery as regulators have started granting publishing licences since late last year after a months-long freeze.

  • 16 Top Growth Stocks Expecting A 50% To 439% Rise This Year

    Palo Alto Networks and Salesforce lead this list of 16 top-rated growth stocks eyeing 50% to 439% EPS growth this year.

  • After Signature Bank Deal, FDIC Is Left With $11 Billion in ‘Toxic Waste’ Loans

    (Bloomberg) -- Signature Bank’s partial takeover by a competitor is notable for what it doesn’t include: $11 billion of loans against a class of New York City apartments whose values have tumbled in recent years.Most Read from BloombergBomb Threat Called In to New York Court Where Trump Hearing HeldUS Studies Ways to Insure All Bank Deposits If Crisis GrowsJPMorgan Owned the LME ‘Nickel’ That Was Actually Bags of StonesSwiss Are On the Hook for $13,500 Each on Credit Suisse BailoutSVB’s Loans to

  • Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories

    Reuters Credit Suisse Bondholders Enraged As $17B Of AT1 Debt To Be Written Down To Zero: What It Means Credit Suisse Group AG (NYSE: CS) said 16 billion Swiss francs ($17.24 billion) of its additional tier 1 (AT1) debt, a type of bond, will be written down to zero on the orders of the Swiss regulator FINMA as part of its rescue merger with UBS Group AG (NYSE: UBS). The decision by the Swiss regulator would mean AT1 bondholders may be left with nothing while shareholders, who sit below bonds in

  • GameStop Shares Surge After It Posts Surprise Profit

    GameStop shares surged more than 40% after the retailer said cost cutting helped it record its first quarterly profit after seven consecutive quarters of losses. GameStop has been working to turn around its business for close to two years under the leadership of a revamped executive team and board of directors. The Grapevine, Texas-based company on Tuesday recorded a net profit of $48.2 million for the three months ended in January, compared with a loss of $147.5 million a year earlier.

  • GameStop Stock Is Soaring on a Surprise Profit. The Short Squeeze Begins.

    GameStop reported a surprise profit in the fiscal fourth quarter, sending the stock soaring in late trading Tuesday. It was the videogame retailer’s first profitable quarter since the one that ended in January 2021. The January quarter includes the holiday season, a key driver of console and software sales.